Caplin Point Laboratories Ltd., incorporated in the year 1990, is a Small Cap company (having a market cap of Rs 19,096.42 Crore) operating in Pharmaceuticals sector. Caplin Point Laboratories Ltd.

Dipan Mehta of Elixir Equities notes that the Trump presidency and earnings season will be major market trends in 2025.

Explore the detailed Caplin Point Laboratories Ltd balance sheet to understand the company’s financial health and stability. This page provides a clear breakdown of key metrics, including total ...

News for Caplin Point Laboratories Ltd. Caplin Point Labs Gets USFDA Nod for Generic Eyedrop - Difluprednate Caplin Point Labs receives USFDA approval for its generic version of Difluprednate eye drop ...

The main driver of this growth was the 28.10% YoY increase in term deposits, which went from Rs 19,802 crore to Rs 25,365 crore.

Despite volatility in the Indian stock market, analysts suggest six stocks for short-term gains, with expected returns ...

Indian benchmark indices closed higher on Friday, driven by auto stocks, after last week's 5% drop. The Nifty 50 rose 0.27% ...

Healthcare stocks were trading in green, with the BSE Healthcare index increasing 25.87 points or 0.06% at 44663.98 at 09:33 IST.

Defendants in the federal discrimination lawsuit brought by the South Florida Muslim Federation against Marriott Coral Springs, the City of Parkland and others have filed a motion to dismiss the case.

The number of former MPs holding coveted passes for the Parliamentary estate has spiked by more than a fifth since July.